Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention

NCT01505790 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

187

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndromes

Interventions

DRUG: PRASUGREL
DRUG: Clopidogrel

Sponsor

Assistance Publique Hopitaux De Marseille